Six hundred trials from high-impact medical journals were classified depending on whether they allowed for the inclusion of patients with localized and/or metastatic disease. Five hundred trials were ...

CAN-2409 resulted in disease-free survival improvements for patients with high-risk, localized prostate cancer. Among patients with localized prostate cancer, the viral immunotherapy CAN-2409 has ...

In the quest for reduced morbidity from radical treatments, tissue-sparing focal therapies are being developed to treat men with localized prostate cancer. However, which patients are most suitable ...

Of various treatment options for higher-risk localized prostate cancer, radical prostatectomy was associated with the best cancer-specific and overall survival, an observational study found. Among ...

This panel was moderated by Dr. Tian Zhang, and featured Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams. Zhang: I would like to kick it off by asking Bruce to tell us a little bit about your ...

The annual cost of Lyme disease in the United States could be nearly $970 million, according to new research. But not all cases of Lyme disease are equally costly. Costs for patients with disseminated ...

This new article publication from Acta Pharmaceutica Sinica B, discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity ...

Actionability of Synthetic Data in a Heterogeneous and Rare Health Care Demographic: Adolescents and Young Adults With Cancer Extracting inclusion and exclusion criteria in a structured, automated ...